Covered recipient · General Payments record
ERWYN CHUA ONG
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$1,980.63
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $530.93 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $184.99 | 8 |
| Lilly USA, LLC | $156.50 | 8 |
| Amgen Inc. | $74.00 | 4 |
| DEXCOM, INC. | $34.16 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $32.67 | 2 |
| Medtronic, Inc. | $15.19 | 1 |
| Novo Nordisk AS | $14.45 | 1 |
| Organon LLC | $11.04 | 1 |
| BETA BIONICS, INC. | $7.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.96 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111666014 | CMS |
| Amgen Inc. | $16.92 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111666010 | CMS |
| Amgen Inc. | $18.94 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111666016 | CMS |
| Amgen Inc. | $23.18 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111666012 | CMS |
| BETA BIONICS, INC. | $7.93 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087887933 | CMS |
| Dexcom, Inc. | $34.16 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153299481 | CMS |
| Insulet Corporation | $23.10 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804646 | CMS |
| Insulet Corporation | $22.18 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804642 | CMS |
| Insulet Corporation | $24.08 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804640 | CMS |
| Insulet Corporation | $15.20 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804638 | CMS |
| Insulet Corporation | $20.29 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811641 | CMS |
| Insulet Corporation | $23.90 | 08/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811639 | CMS |
| Insulet Corporation | $17.49 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116826026 | CMS |
| Insulet Corporation | $38.75 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116826024 | CMS |
| Lilly USA, LLC | $20.65 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136167500 | CMS |
| Lilly USA, LLC | $22.64 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136173132 | CMS |
| Lilly USA, LLC | $12.58 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136175260 | CMS |
| Lilly USA, LLC | $20.63 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136173134 | CMS |
| Lilly USA, LLC | $15.26 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136175262 | CMS |
| Lilly USA, LLC | $27.02 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136175264 | CMS |
| Lilly USA, LLC | $24.37 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136167502 | CMS |
| Lilly USA, LLC | $13.35 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136167504 | CMS |
| Medtronic, Inc. | $15.19 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119554860 | CMS |
| Novo Nordisk Inc | $14.45 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096873712 | CMS |
| Organon Llc | $11.04 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136190072 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $15.12 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139165268 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $17.55 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139165270 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.